RESULTS
Leading Injectable Diabetes Brand Increased Adherence by 2.9 Fills per Patient

The client-branded adherence program delivered a 2.9 incremental fill increase for the top-tier diabetes brand, representing a 57% lift in adherence (source: Crossix).